HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Diehl, J. T. Articles by Cosgrove, D. M. Search for Related Content PubMed PubMed Citation Articles by Diehl, J. T. Articles by Cosgrove, D. M.

The Annals of Thoracic Surgery, Vol 34, 674-679, Copyright © 1982 by The Society of Thoracic Surgeons

ARTICLES

Clinical comparison of hetastarch and albumin in postoperative cardiac patients

JT Diehl, JL Lester 3d and DM Cosgrove

Hetastarch, 6% hydroxyethyl starch solution, is an artificial colloid proposed for use as a volume expander. There is concern that hetastarch, like dextran, may adversely affect coagulation. To compare the effects of hetastarch with 5% albumin in postoperative patients, 60 consecutive patients who underwent coronary artery bypass were prospectively randomized into two study groups. Both groups were comparable in all respects preoperatively. Group 1 (27 patients) received a mean of 1,241 ml of 5% albumin and Group 2 (33 patients) a mean of 1,210 ml of hetastarch as volume replacement within the first 24 postoperative hours. Indices of postoperative hepatic, renal, and pulmonary function did not differ significantly between the groups immediately postoperatively, at 24 hours postoperatively, or at 7 days postoperatively. Hematocrits, platelet counts, prothrombin times, partial thromboplastin times, and serum fibrinogen levels were comparable between the two groups at all times. The mean volume of chest tube drainage did not differ between the groups (Group 1, 495 +/- 216 ml; Group 2, 637 +/- 402 ml; not significant), and no patient required reexploration for bleeding. Eighteen percent of Group 1 and 15% of Group 2 patients received banded blood during their hospitalization and required similar amounts (Group 1, 0.37 unit per patient; Group 2, 0.36 unit per patient; not significant). The use of hetastarch as a postoperative volume expander after myocardial revascularization is safe and effective, and results in substantial financial savings.

This article has been cited by other articles:

				Evidence-based Colloid Use in the Critically Ill: American Thoracic Society Consensus Statement Am. J. Respir. Crit. Care Med., December 1, 2004; 170(11): 1247 - 1259. [Full Text] [PDF]

				R. C. Arora, J.-F. Legare, K. J. Buth, J. A. Sullivan, and G. M. Hirsch Identifying Patients at Risk of Intraoperative and Postoperative Transfusion in Isolated CABG: Toward Selective Conservation Strategies Ann. Thorac. Surg., November 1, 2004; 78(5): 1547 - 1554. [Abstract] [Full Text] [PDF]

				M. E. Barron, M. M. Wilkes, and R. J. Navickis A Systematic Review of the Comparative Safety of Colloids Arch Surg, May 1, 2004; 139(5): 552 - 563. [Abstract] [Full Text] [PDF]

				R. Salenger, J. S. Gammie, and T. J. Vander Salm Postoperative Care of Cardiac Surgical Patients Card. Surg. Adult, January 1, 2003; 2(2003): 439 - 469. [Full Text]

				P.R. Belcher and E.W. Muriithi Coronary artery bypass grafting surgery without the routine application of blood products: is it feasible? Eur. J. Cardiothorac. Surg., November 1, 2001; 20(5): 1078 - 1078. [Full Text] [PDF]

				M. M. Wilkes, R. J. Navickis, and W. J. Sibbald Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: a meta-analysis of postoperative bleeding Ann. Thorac. Surg., August 1, 2001; 72(2): 527 - 533. [Abstract] [Full Text] [PDF]

				D. L Zarro, D. A Palanzo, and T. G Phillips Albumin in the pump prime: its effect on postoperative weight gain Perfusion, March 1, 2001; 16(2): 129 - 135. [Abstract] [PDF]

				J. E. Knutson, J. A. Deering, F. W. Hall, G. A. Nuttall, D. R. Schroeder, R. D. White, and C. J. Mullany Does Intraoperative Hetastarch Administration Increase Blood Loss and Transfusion Requirements After Cardiac Surgery? Anesth. Analg., April 1, 2000; 90(4): 801 - 807. [Abstract] [Full Text] [PDF]

				I. Tigchelaar, R. C. G. Huet, P. W Boonstra, and W. van Oeveren Comparison of three plasma expanders used as priming fluids in cardiopulmonary bypass patients Perfusion, September 1, 1998; 13(5): 297 - 303. [Abstract] [PDF]

				J. T. Cope, D. Banks, M. C. Mauney, T. Lucktong, K. S. Shockey, I. L. Kron, and C. G. Tribble Intraoperative Hetastarch Infusion Impairs Hemostasis After Cardiac Operations Ann. Thorac. Surg., January 1, 1997; 63(1): 78 - 83. [Abstract] [Full Text]

				R. L. Bick Evaluation of a New Hydroxyethyl Starch, Preparation (HextendTM) on Selected Coagulation Parameters Clinical and Applied Thrombosis/Hemostasis, June 1, 1995; 1(3): 215 - 229. [PDF]

				L. Sandrelli, O. Alfieri II, and W. van Oeveren The problem of priming solutions? The solution of priming problems Perfusion, July 1, 1992; 7(3): 217 - 221. [PDF]

				L. B. McGrath, L. Gonzalez-Lavin, and M. J. Neary Comparison of dextran 40 with albumin and Ringer's lactate as components of perfusion prime for cardiopulmonary bypass in patients undergoing myocardial revascularization Perfusion, January 1, 1989; 4(1): 41 - 49. [Abstract] [PDF]